SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

AIMS: Impaired myocardial sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) activity is a hallmark of failing hearts, and SERCA2a gene therapy improves cardiac function in animals and patients with heart failure (HF). Deregulation of microRNAs has been demonstrated in HF pathophysiology. We studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumarswamy, Regalla, Lyon, Alexander R., Volkmann, Ingo, Mills, Adam M., Bretthauer, Julia, Pahuja, Aanchal, Geers-Knörr, Cornelia, Kraft, Theresia, Hajjar, Roger J., Macleod, Kenneth T., Harding, Sian E., Thum, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Fasttrack Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341631/
https://www.ncbi.nlm.nih.gov/pubmed/22362515
http://dx.doi.org/10.1093/eurheartj/ehs043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341631/
https://www.ncbi.nlm.nih.gov/pubmed/22362515
http://dx.doi.org/10.1093/eurheartj/ehs043

Ejemplares similares